Full Text View
Tabular View
No Study Results Posted
Related Studies
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
This study has been suspended.
Study NCT00068419   Information provided by National Cancer Institute (NCI)
First Received: September 10, 2003   Last Updated: July 2, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Desmoid Tumor
Additional conditions recognized in this trial
Fibromatosis, Aggressive
More general conditions related to this trial
Fibroma
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Neoplasms, Fibrous Tissue
Interventions listed in this trial
sulindac
tamoxifen citrate
Additional drug interventions recognized in this trial
Tamoxifen
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antirheumatic Agents
Bone Density Conservation Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Estrogen Antagonists
Estrogen Receptor Modulators
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Selective Estrogen Receptor Modulators
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Children's Oncology Group
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services